Disorder of sex development-intellectual disability syndrome
diseaseOn this page
Also known as disorder of sex development intellectual disabilityMale pseudohermaphroditism intellectual disability syndrome, Verloes typemale pseudohermaphroditism/mental retardation syndrome, Verloes typepseudohermaphroditism-intellectual disability syndromeVerloes Gillerot Fryns syndromeVerloes-Gillerot-Fryns syndrome
Summary
Disorder of sex development-intellectual disability syndrome (MONDO:0010824) is a disease. A subtype of 46 XY differences of sex development — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 23
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 3 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
23 HPO clinical features (Orphanet curated; top 23 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000046 | Small scrotum | Very frequent (80-99%) |
| HP:0000135 | Hypogonadism | Very frequent (80-99%) |
| HP:0000233 | Thin vermilion border | Very frequent (80-99%) |
| HP:0000271 | Abnormality of the face | Very frequent (80-99%) |
| HP:0000322 | Short philtrum | Very frequent (80-99%) |
| HP:0000470 | Short neck | Very frequent (80-99%) |
| HP:0000490 | Deeply set eye | Very frequent (80-99%) |
| HP:0000664 | Synophrys | Very frequent (80-99%) |
| HP:0001249 | Intellectual disability | Very frequent (80-99%) |
| HP:0002162 | Low posterior hairline | Very frequent (80-99%) |
| HP:0002714 | Downturned corners of mouth | Very frequent (80-99%) |
| HP:0002808 | Kyphosis | Very frequent (80-99%) |
| HP:0002857 | Genu valgum | Very frequent (80-99%) |
| HP:0003196 | Short nose | Very frequent (80-99%) |
| HP:0003298 | Spina bifida occulta | Very frequent (80-99%) |
| HP:0004349 | Reduced bone mineral density | Very frequent (80-99%) |
| HP:0006610 | Wide intermamillary distance | Very frequent (80-99%) |
| HP:0008551 | Microtia | Very frequent (80-99%) |
| HP:0008625 | Severe sensorineural hearing impairment | Very frequent (80-99%) |
| HP:0008736 | Hypoplasia of penis | Very frequent (80-99%) |
| HP:0010306 | Short thorax | Very frequent (80-99%) |
| HP:0010720 | Abnormal hair pattern | Very frequent (80-99%) |
| HP:0000358 | Posteriorly rotated ears | Very frequent (80-99%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | disorder of sex development-intellectual disability syndrome |
| Mondo ID | MONDO:0010824 |
| MeSH | C535693 |
| OMIM | 600122 |
| Orphanet | 2983 |
| SNOMED CT | 719450007 |
| UMLS | C1838611 |
| MedGen | 325469 |
| GARD | 0004550 |
| Is cancer (heuristic) | no |
Also known as: disorder of sex development intellectual disability · Male pseudohermaphroditism intellectual disability syndrome, Verloes type · male pseudohermaphroditism/mental retardation syndrome, Verloes type · pseudohermaphroditism-intellectual disability syndrome · Verloes Gillerot Fryns syndrome · Verloes-Gillerot-Fryns syndrome
Disease family
This is a subtype of 46 XY differences of sex development. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › reproductive system disorder › gonadal disorder › disorder of sexual differentiation › 46 XY differences of sex development › disorder of sex development-intellectual disability syndrome
Related subtypes (23): Frasier syndrome, WAGR syndrome, Denys-Drash syndrome, familial adrenal hypoplasia with absent pituitary luteinizing hormone, PAGOD syndrome, XY type gonadal dysgenesis-associated anomalies syndrome, 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency, 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency, X-linked myotubular myopathy-abnormal genitalia syndrome, alpha thalassemia-X-linked intellectual disability syndrome, chondrodysplasia-pseudohermaphroditism syndrome, 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome, sudden infant death-dysgenesis of the testes syndrome, Meacham syndrome, Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency, distal monosomy 9p, dysmorphism-short stature-deafness-disorder of sex development syndrome, 46,XY partial gonadal dysgenesis, testicular agenesis, 46,XY ovotesticular disorder of sex development, penile agenesis, androgen insensitivity syndrome, male pseudohermaphroditism due to defective lh molecule
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.